Public access

Tuberculoma of the central nervous system

AR DeLance, M Safaee, MC Oh, AJ Clark, G Kaur, MZ Sun, AW Bollen, ...

Journal of Clinical Neuroscience 20 (10), 1333-1341, 2013

Mandates: US National Institutes of Health, Doris Duke Charitable Foundation

Current management of choroid plexus carcinomas

MZ Sun, MC Oh, ME Ivan, G Kaur, M Safaee, JM Kim, JJ Phillips, ...

Neurosurgical review 37, 179-192, 2014

Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Doris …

Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1)

MJ Fisher, DTW Jones, Y Li, X Guo, PS Sonawane, AJ Waanders, ...

Acta neuropathologica 141, 605-617, 2021

Mandates: US National Institutes of Health, Children's Tumor Foundation, USA

G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells

G Kaur, J Kim, R Kaur, I Tan, O Bloch, MZ Sun, M Safaee, MC Oh, ...

Journal of Clinical Neuroscience 20 (7), 1014-1018, 2013

Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Doris …

Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective

R Mathur, Q Wang, PG Schupp, A Nikolic, S Hilz, C Hong, NR Grishanina, ...

Cell 187 (2), 446-463. e16, 2024

Mandates: Chan Zuckerberg Initiative

Loss of H3K27 trimethylation by immunohistochemistry is frequent in oligodendroglioma, IDH-mutant and 1p/19q-codeleted, but is neither a sensitive nor a specific marker

M Pekmezci, JJ Phillips, F Dirilenoglu, T Atasever-Rezanko, T Tihan, ...

Acta Neuropathologica 139, 597-600, 2020

Mandates: US National Institutes of Health

EGFR and EGFRvIII coopt host defense pathways, promoting progression in glioblastoma

Z An, QW Fan, L Wang, H Yoda, MJ Barata, D Jimenez-Morales, ...

Neuro-Oncology, noae182, 2024

Mandates: Cancer Research UK

Available somewhere: 198

The immune landscape of cancer

V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...

Immunity 48 (4), 812-830. e14, 2018

Mandates: US Department of Defense, US National Institutes of Health

Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment

Q Wang, B Hu, X Hu, H Kim, M Squatrito, L Scarpace, AC DeCarvalho, ...

Cancer cell 32 (1), 42-56. e6, 2017

Mandates: US National Institutes of Health

New brain tumor entities emerge from molecular classification of CNS-PNETs

D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ...

Cell 164 (5), 1060-1072, 2016

Mandates: US National Institutes of Health, Helmholtz Association, Cancer Research UK …

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn, AM Stütz, X Wang, ...

Nature 506 (7489), 445-450, 2014

Mandates: US National Institutes of Health, Canadian Cancer Society, Canadian …

VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex

KV Lu, JP Chang, CA Parachoniak, MM Pandika, MK Aghi, D Meyronet, ...

Cancer cell 22 (1), 21-35, 2012

Mandates: US National Institutes of Health, Canadian Institutes of Health Research

[HTML] oup.com

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

N Butowski, H Colman, JF De Groot, AM Omuro, L Nayak, PY Wen, ...

Neuro-oncology 18 (4), 557-564, 2015

Mandates: US National Institutes of Health

[PDF] jamanetwork.com

Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed …

AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ...

JAMA oncology 6 (4), 495-503, 2020

Mandates: US National Institutes of Health, State of Califonia

Diffuse midline gliomas with histone H3‐K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations

DA Solomon, MD Wood, T Tihan, AW Bollen, N Gupta, JJJ Phillips, ...

Brain pathology 26 (5), 569-580, 2016

Mandates: US National Institutes of Health

[PDF] oup.com

Pediatric high-grade glioma: biologically and clinically in need of new thinking

C Jones, MA Karajannis, DTW Jones, MW Kieran, M Monje, SJ Baker, ...

Neuro-oncology 19 (2), 153-161, 2017

Mandates: Cancer Research UK, Brain Tumour Charity, UK

Cytogenetic prognostication within medulloblastoma subgroups

DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ...

Journal of clinical oncology 32 (9), 886-896, 2014

Mandates: US National Institutes of Health, Canadian Institutes of Health Research …

Tissue mechanics promote IDH1-dependent HIF1α–tenascin C feedback to regulate glioblastoma aggression

YA Miroshnikova, JK Mouw, JM Barnes, MW Pickup, JN Lakins, Y Kim, ...

Nature cell biology 18 (12), 1336-1345, 2016

Mandates: US National Science Foundation, US National Institutes of Health

[HTML] oup.com

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

A Banerjee, RI Jakacki, A Onar-Thomas, S Wu, T Nicolaides, ...

Neuro-oncology 19 (8), 1135-1144, 2017

Mandates: US National Institutes of Health